|
🐜
|
Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS).
76 auth.
S. Chinn,
C. Luczynska,
D. Jarvis,
E. Khaled,
Austria W. Popp,
J. Abramson,
F. V. B. B. P. Vermeire,
M. Dahl,
Estonia R. Jögi,
F. Neukirch,
R. Liard,
I. Pin,
C. P. A. T. D. Teculescu,
J. Wichmann,
Greece N. Papageorgiou,
...
P. Avarlis,
M. Gaga,
C. Marossis,
Iceland T. Gislason D. Gislason,
India R. Chowgule,
Ireland J. Prichard,
S. Allwright,
D. Macleod,
C. Bucca,
C. Romano,
R. Marco,
V. Cascio,
C. Campello,
A. Marinoni,
I. Cerveri,
L. Casali,
S. L. Crane,
E. O. N. A. Gulsvik,
Portugal R. Avila,
R. Marques,
C. Loureiro,
C. Chieira,
R. Cordeiro,
J. A. Marques,
J. Alves,
Spain J. Anto,
J. Castellsagué,
J. Sunyer,
J. Soriano,
M. Roca,
N. Muniozguren,
J. R. González,
A. Capelastegui,
J. Castillo,
E. Almar,
J. Pereira,
J. Sánchez,
J. Quirós,
I. Huerta,
Sweden G. Boman,
C. Janson,
E. Björnsson,
L. Rosenhall,
E. Norrman,
B. Lundbäck,
N. Lindholm,
P. Plaschke,
Switzerland U. Ackermann Liebrich,
N. Künzli,
A. Perruchoud,
United Kingdom M. Burr,
J. Layzell,
R. Hall,
B. Harrison,
J. Stark,
C. Florey,
A. Pereira,
R. Clark,
Usa S. Buist,
W. Vollmer,
M. Osborne
|
9 |
1996 |
9
🐜
|
|
🐢
|
The acute-phase response after bisphosphonate administration
7 auth.
Dr. S. Adami,
A. Bhalla,
R. Dorizzi,
F. Montesanti,
S. Rosini,
G. Salvagno,
...
V. Cascio
|
7 |
1987 |
7
🐢
|
|
🐜
|
Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation
8 auth.
A. Pasini,
U. Garbin,
M. C. Nava,
C. Stranieri,
A. Davoli,
T. Sawamura,
...
V. Cascio,
L. Cominacini
|
7 |
2005 |
7
🐜
|
|
🐢
|
Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton.
8 auth.
S. Adami,
G. Salvagno,
G. Guarrera,
G. Bianchi,
R. Dorizzi,
S. Rosini,
...
G. Mobilio,
V. Cascio
|
6 |
1985 |
6
🐢
|
|
🐢
|
Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control
10 auth.
L. Cominacini,
A. Pasini,
U. Garbin,
A. Davoli,
A. Santis,
M. Campagnola,
...
Annamaria Rigoni,
M. Zenti,
Paolo Moghetti,
V. Cascio
|
6 |
1995 |
6
🐢
|
|
🐜
|
Troglitazone Reduces LDL Oxidation and Lowers Plasma E-selectin Concentration in NIDDM Patients
10 auth.
L. Cominacini,
U. Garbin,
A. Pasini,
M. Campagnola,
A. Davoli,
E. Foot,
...
Giuseppe Sighieri,
A. Sironi,
V. Cascio,
E. Ferrannini
|
6 |
1998 |
6
🐜
|
|
🐢
|
Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease.
12 auth.
L. Cominacinia,
U. Garbin,
A. Pastorino,
A. Davoli,
M. Campagnola,
A. Santis,
...
C. Pasini,
G. Faccini,
M. T. Trevisan,
L. Bertozzo,
F. Pasini,
V. Cascio
|
6 |
1993 |
6
🐢
|
|
🐢
|
Serum 25‐hydroxyvitamin D levels modulate the acute‐phase response associated with the first nitrogen‐containing bisphosphonate infusion
9 auth.
F. Bertoldo,
S. Pancheri,
S. Zenari,
S. Boldini,
B. Giovanazzi,
M. Zanatta,
...
M. Valenti,
L. Carbonare,
V. Cascio
|
6 |
2010 |
6
🐢
|
|
🐢
|
E-Selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress
9 auth.
L. Cominacini,
A. Pasini,
U. Garbin,
M. Campagnola,
A. Davoli,
A. Rigoni,
...
M. Zenti,
A. Pastorino,
V. Cascio
|
6 |
1997 |
6
🐢
|
|
🐢
|
Oxidized low‐density lipoprotein increases the production of intracellular reactive oxygen species in endothelial cells: inhibitory effect of lacidipine
8 auth.
L. Cominacini,
U. Garbin,
A. Pasini,
A. Davoli,
M. Campagnola,
A. Pastorino,
...
G. Gaviraghi,
V. Cascio
|
6 |
1998 |
6
🐢
|
|
🐢
|
Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle
F. Bertoldo,
D. Santini,
V. Cascio
|
6 |
2007 |
6
🐢
|
